MedPath

Comparative study on efficacy of intralesional botulinum toxin injection, intralesional steroid, and topical vitaminD/steroids combination injection in nail psoriasis patients

Phase 4
Conditions
ail psoriasis patients with at least 4 fingernails involvement.
nail psoriasis, psoriatic nail, botulinum toxin injection
Registration Number
TCTR20210704002
Lead Sponsor
Chulabhorn International College of Medicine, Thammasat University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
18
Inclusion Criteria

1. Patient aged at least 20 years old.
2. Psoriatic nail patients who have at least 4 psoriatic nails.
3. Each enrolled nail has target NAPSI score at least 3 points.

Exclusion Criteria

1. Patients refusel to participate the study
2. Patients are using topical nail therapies within 2 weeks.
3. Patients are receiving oral therapies within 4 weeks.
4. Patients have active nail infection.
5. Patient with sensitivity or allergy to constituents of the botulinum toxin product, vitamin D , corticosteroid, cows milk protein or lidocaine
6. Patient with neuromuscular disorder or peripheral motor neuropathic disease (e.g. amyotrophic lateral sclerosis, myasthenia gravis, Lambert Eaton syndrome, myopathies)
7. Pregnancy or breastfeeding
8. Unrealistic expectation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
nail psoriasis at 4 and 6 months after end of the first intervention target NAPSI score,Pain of nail injection at 0 and 8 weeks of intervention pain score 0-10,Complication of nail psoriasis treatment at 8, 16, and 24 weeks side effect
Secondary Outcome Measures
NameTimeMethod
Satisfaction of nail psoriasis improvement at 8, 16, and 24 weeks Patient's satisfaction 0-4
© Copyright 2025. All Rights Reserved by MedPath